JNJ

Johnson & Johnson

Company with tickers: JNJ

CIK

200406

CUSIP

478160104

Shares Outstanding

2,407,216,971

13F Activity (30d)

1459 filings 1359 filers

Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.

Date	Insider	Role	Type	Shares	Price	Value	After
2026-05-01	REED JOHN C	EVP, Innovative Medicine, R&D	Convert	25,255	—	—	0
2026-05-01	REED JOHN C	EVP, Innovative Medicine, R&D	Convert	25,255	—	—	35,913
2026-05-01	REED JOHN C	EVP, Innovative Medicine, R&D	Tax	11,002	$229.85	$2,528,810	24,911
2026-04-23	Joly Hubert	Director	Award	975	—	—	9,183
2026-04-23	Doudna Jennifer A	Director	Award	975	—	—	10,899
2026-04-23	Beckerle Mary C	Director	Award	975	—	—	16,797
2026-04-23	McClellan Mark B.	Director	Award	975	—	—	21,278
2026-04-23	Pinto Daniel E	President & COO	Award	1,712	—	—	2,174
2026-04-23	MORIKIS JOHN G	Director	Award	1,540	—	—	1,540
2026-04-23	WEINBERGER MARK A	Director	Award	975	—	—	12,010
2026-04-23	West Nadja	Director	Award	975	—	—	7,730
2026-04-23	HEWSON MARILLYN A	Director	Award	975	—	—	15,487
2026-04-23	Johnson Paula A	Director	Award	975	—	—	5,359
2026-04-23	Woods Eugene A.	Director	Award	975	—	—	6,215
2026-03-10	Pinto Daniel E	President & COO	Award	129	$242.14	$31,236	462
2026-03-10	Woods Eugene A.	Director	Award	154	$242.14	$37,290	5,240
2026-03-10	HEWSON MARILLYN A	Director	Award	206	$242.14	$49,881	14,512
2026-02-27	Decker Robert J	VP Corporate Controller	Convert	4,075	$115.67	$471,355	27,757
2026-02-27	Decker Robert J	VP Corporate Controller	Other	646	—	—	646
2026-02-27	Decker Robert J	VP Corporate Controller	Convert	4,075	—	—	0
2026-02-27	Decker Robert J	VP Corporate Controller	Other	134	—	—	134
2026-02-27	Decker Robert J	VP Corporate Controller	Sell	4,075	$247.87	$1,010,070	23,682
2026-02-20	Schmid Timothy	EVP, WW Chair, MedTech	Other	745	—	—	745
2026-02-20	Schmid Timothy	EVP, WW Chair, MedTech	Other	46	—	—	46
2026-02-20	Schmid Timothy	EVP, WW Chair, MedTech	Sell	1,322	$245.66	$324,763	25,447
2026-02-18	Schmid Timothy	EVP, WW Chair, MedTech	Convert	13,625	$115.67	$1,576,004	40,394
2026-02-18	Schmid Timothy	EVP, WW Chair, MedTech	Convert	13,625	—	—	0
2026-02-18	Schmid Timothy	EVP, WW Chair, MedTech	Convert	8,998	—	—	0
2026-02-18	Schmid Timothy	EVP, WW Chair, MedTech	Sell	8,998	$244.53	$2,200,281	26,769
2026-02-18	Schmid Timothy	EVP, WW Chair, MedTech	Convert	8,998	$129.51	$1,165,331	35,767
2026-02-18	Schmid Timothy	EVP, WW Chair, MedTech	Sell	13,625	$244.20	$3,327,225	26,769
2026-02-17	Wolk Joseph J	Exec VP, CFO	Sell	24,961	$242.68	$6,057,535	14,000
2026-02-17	REED JOHN C	EVP, Innovative Medicine, R&D	Sell	2,283	$243.00	$554,769	10,658
2026-02-17	Wolk Joseph J	Exec VP, CFO	Convert	19,241	—	—	0
2026-02-17	Wolk Joseph J	Exec VP, CFO	Sell	12,066	$242.87	$2,930,469	38,961
2026-02-17	REED JOHN C	EVP, Innovative Medicine, R&D	Convert	29,927	—	—	59,854
2026-02-17	REED JOHN C	EVP, Innovative Medicine, R&D	Sell	21,721	$243.00	$5,278,203	12,941
2026-02-17	Swanson James D.	EVP, CIO	Convert	20,521	—	—	0
2026-02-17	Wolk Joseph J	Exec VP, CFO	Convert	33,386	$131.94	$4,404,949	72,347
2026-02-17	Swanson James D.	EVP, CIO	Convert	20,521	$164.62	$3,378,167	46,219
2026-02-17	REED JOHN C	EVP, Innovative Medicine, R&D	Convert	21,721	—	—	21,721
2026-02-17	Wolk Joseph J	Exec VP, CFO	Convert	33,386	—	—	33,000
2026-02-17	Swanson James D.	EVP, CIO	Sell	20,521	$242.70	$4,980,447	25,698
2026-02-17	Wolk Joseph J	Exec VP, CFO	Convert	19,241	$115.67	$2,225,606	58,202
2026-02-17	REED JOHN C	EVP, Innovative Medicine, R&D	Convert	29,927	$156.15	$4,673,101	42,868
2026-02-17	Wolk Joseph J	Exec VP, CFO	Sell	33,386	$242.75	$8,104,452	38,961
2026-02-17	Wolk Joseph J	Exec VP, CFO	Convert	12,066	$129.51	$1,562,668	51,027
2026-02-17	Broadhurst Vanessa	EVP, Global Corp Affairs	Sell	6,197	$243.39	$1,508,288	23,003
2026-02-17	Wolk Joseph J	Exec VP, CFO	Convert	12,066	—	—	0
2026-02-17	Wolk Joseph J	Exec VP, CFO	Sell	19,241	$242.99	$4,675,371	38,961

Showing 1–50 of 1,818 transactions